Highstreet Asset Management’s AbbVie ABBV Stock Holding History

Highstreet Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$2.02M	Buy	22,756 +14,012	+160%	+$1.16M	0.09%	92
2019 Q3	$662K	Sell	8,744 -11,624	-57%	-$797K	0.03%	177
2019 Q2	$1.48M	Sell	20,368 -1,039	-5%	-$81.7K	0.07%	106
2019 Q1	$1.73M	Buy	21,407 +515	+2%	+$42.1K	0.1%	96
2018 Q4	$1.93M	Buy	20,892 +10,404	+99%	+$915K	0.12%	94
2018 Q3	$992K	Hold	10,488	–	–	0.06%	161
2018 Q2	$972K	Sell	10,488 -2,028	-16%	-$198K	0.06%	139
2018 Q1	$1.19M	Sell	12,516 -11,050	-47%	-$1.21M	0.08%	108
2017 Q4	$2.28M	Buy	23,566 +3,698	+19%	+$349K	0.13%	77
2017 Q3	$1.76M	Buy	19,868 +815	+4%	+$62K	0.17%	72
2017 Q2	$1.38M	Buy	+19,053	New	+$1.28M	0.15%	90
2017 Q1	–	Sell	-7,277	Closed	-$456K	–	143
2016 Q4	$456K	Sell	7,277 -13,864	-66%	-$846K	0.16%	136
2016 Q3	$1.33M	Buy	21,141 +10,068	+91%	+$652K	0.46%	62
2016 Q2	$686K	Buy	+11,073	New	+$675K	0.24%	96
2016 Q1	–	Sell	-83,200	Closed	-$4.93M	–	149
2015 Q4	$4.93M	Buy	+83,200	New	+$4.79M	1.05%	37
2015 Q2	–	Sell	-14,283	Closed	-$836K	–	142
2015 Q1	$836K	Buy	+14,283	New	+$863K	0.25%	111

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Highstreet Asset Management's ABBV Position: Q4 2019 in Review

Highstreet Asset Management increased its AbbVie (ABBV) stake by 160% in Q4 2019, buying an estimated $1.16M and bringing the position to 22,756 shares worth $2.02M. The position accounts for 0.09% of the portfolio, ranked #92.

Highstreet Asset Management first reported a position in ABBV in Q1 2015 and has held it in 16 quarters since. The position peaked at $4.93M in Q4 2015. 2,244 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

Highstreet Asset Management held 22,756 shares of AbbVie worth $2.02M as of Q4 2019.
Highstreet Asset Management bought 14,012 AbbVie shares in Q4 2019, an estimated $1.16M.
AbbVie made up 0.09% of Highstreet Asset Management's portfolio in Q4 2019, its #92 holding.
Highstreet Asset Management first reported a position in AbbVie in Q1 2015 and has held it in 16 quarters since.
Highstreet Asset Management's AbbVie position peaked at $4.93M in Q4 2015.
2,244 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.